Labomar S p A : Economic and Financial Consolidated Results 1H2021 – Labomar Presentation

Labomar Presentation

10 OCTOBER 2019

1° H 2021 Results

SEPTEMBER 27, 2021

MASTER

Today's Speakers

WALTER	CLAUDIO
BERTIN	DE NADAI

FOUNDER & CEO

IR & BOARD DIRECTOR

CLAUDIO CRESPAN

CFO

FRANCESCO

DA RIVA

HEAD OF SALES

FOUNDED LABOMAR IN 1998 FROM

THE "FARMACIA BERTIN"

MEMBER OF ASSINDUSTRIA VENETO CENTRO SINCE 2012

GRADUATED IN PHARMACEUTICAL

SCIENCE AND COMPLETED A

DEGREE IN LEAN MANAGEMENT

CONSULTANT FOR LABOMAR SINCE

2007 ON FINANCIAL STRATEGY AND

BOARD MEMBER SINCE 2018, HE LED

THE ASSET DEAL ON IMPORTFAB AND

WELCARE

AFTER 13 YEARS AS CFO AND

GENERAL MANAGER OF AN ITALIAN SME AND A PAST ENTREPRENEURIAL

EXPERIENCE IN AGRI-FOOD, HE

FOUNDED BMODEL (CORPORATE

FINANCE BOUTIQUE)

JOINED LABOMAR GROUP IN 2021 AND APPOINTED AS CFO.

15 YEARS IN EXTENSIVE PREVIOUS

EXPERIENCE AS CFO AND M&A IN

INTERNATIONAL STRUCTURED

COMPANIES, PREVIOUS

EXPERIENCE IN A BIG4 AUDIT FIRM.

VICE PRESIDENT OF ANDAF

NORTH EAST (CFO ASSOCIATION)

SIGNIFICANT EXPERIENCE IN

LABOMAR, FIRST AS HEAD OF

FOREIGN SALES AND SINCE THE

BEGINNING OF 2020 AS HEAD OF

SALES AND COMMERCIAL NETWORKS

EXTENSIVE PREVIOUS EXPERIENCE AS

SENIOR CONSULTANT IN STRATEGY

AND BUSINESS PLANNING

EDUCATION: MASTER IN

MANAGEMENT, ACCOUNTING AND

CONTROL AT BOCCONI UNIVERSITY

2

GROUP OVERVIEW

LABOMAR IS THE NEW FRONTIER

RESEARCH-DRIVEN FULL SERVICE CDMO OPERATING MAINLY IN

THE DIETARY SUPPLEMENTS AND MEDICAL DEVICES SEGMENTS

LEVERAGING INTERNALLY-DEVELOPED PATENTS AND

A FULL RANGE OF PHARMACEUTICAL FORMS

PROVIDING HIGH-GRADE VALUE-ADDED SOLUTIONS TO

INTERNATIONAL LIFE SCIENCES PLAYERS

HIGH ATTENTION TO SUSTAINABILITY, FOR PEOPLE & CUSTOMERS,

INNOVATION AND ETHICS

THE CDMO «2.0»

Click to edit Sources and Notes

4

20+ Years History of Continuous Development

LABOMAR BUILDS VALUABLE RELATIONSHIPS WITH THE BIG PHARMA AND STARTS DEVELOPING FOREIGN MARKETS

1998		2011		2018		2020
FOUNDATION OF		FOUNDATION OF			AUGUST,
		JANUARY
LABOMAR FROM
	LABIOTRE S.R.L., TO		DR BERTIN		STATUTE CHANGE
THE PHARMACY OF		GUARANTEE THE
		BUYS BACK
DR. BERTIN		HIGHEST POSSIBLE
		MINORITIES
		QUALITY OF RAW
			AND OWNS 100%
		MATERIALS
			OF
				LABOMAR			COMING
	2004					OCTOBER,
					SOON
	LABOMAR BEGINS ITS					LISTING ON MILAN
		2015			L6
	TRANSFORMATION			2019	STOCK EXCHANGE
			NEW
	FROM		ROLL-OFF OF THE		NOVEMBER,		HEADQUARTER
	PHARMACEUTICAL LAB		BRAND-NEW,
			ACQUISITION OF		AND
	TO INDUSTRIAL	ATTAINMENT OF THE	PHARMAGRADE
		IMPORTFAB,		PRODUCTION
	MANUFACTURING	GMP AND ISO 9001	STANDARD
		CANADA-BASED		PLANT
	COMPANY	CERTIFICATIONS	L3 PLANT
		PHARMA CMO		CONSTRUCTION

2003

FOUNDATION OF LABOMAR RESEARCH, THE R&D BRANCH

OF LABOMAR; THE COMPANY STARTS BUILDING ITS RESEARCH-DRIVEN DNA

2012	Since 2016
FONDO ITALIANO	START OF THE
D'INVESTIMENTO	LEAN
INVESTS IN	TRANSFORMATION
LABOMAR'S	PROCESS
EQUITY

2008

LABOMAR,

STARTS BUILDING

A COMMITTED, QUALIFIED

MANAGEMENT TEAM

EQUITY INVESTMENT (5%) IN PROJECT ZERO SRL, DEVELOPING VERTICAL FARMING TECHNIQUES

FOR VEGETAL EXTRACTS ZEROCODE OF ETHICS

ESTABLISHMENT OF HERBAE SRL (NOW LABOMAR NEXT SRL) PRODUCING FINISHED VEGETAL RAW MATERIALS USING ZERO TECHNOLOGY

JULY, 2021

ACQUISITION OF THE MAJORITY OF WELCARE RESEARCH SRL ITALIAN COMPANY SPECIALIZED IN WOUND HEALING MEDICAL DEVICES

LABOMAR IS WORKING TO SPUR FUTURE GROWTH, ORGANICALLY AND BY M&A

Source: Management

5